Thyroid News

The FDA granted fast track designation for an investigational parathyroid hormone 1 receptor agonist to treat hypoparathyroidism, according to an industry press release.

Adults with low-risk papillary thyroid cancer reported low levels of decision regret for their disease management choice at 1 year, regardless of whether they chose active surveillance or surgery, according to findings published in Thyroid.

Approximately 77,000 people in the U.S. have hypoparathyroidism due to absent or subphysiological levels of parathyroid hormone.

Adults who undergo surgery to treat hyperparathyroidism have similar rates of fracture after surgery as healthy controls, according to data published in The Journal of Clinical Endocrinology & Metabolism.

More than half of adults with hypothyroidism have self-reported high levels of negative feelings and social withdrawal, or a type D personality, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.

Adults with hyperthyroidism who undergo surgery or receive radioactive iodine therapy have a lower risk for major adverse cardiovascular events than those receiving antithyroid drugs, according to data published in JAMA Network Open.

Adults who develop hypoparathyroidism after a total thyroidectomy have an increased risk for all-cause mortality compared with the general population, but only if the indication for their surgery was cancer, according to study data.

A class of endocrine-disrupting chemical called per- and polyfluoroalkyl substances (PFAS) is no longer being used in food packaging in the U.S., according to an announcement from the FDA.

Just over a century ago, much of the U.S. population experienced disfiguring and debilitating disorders related to iodine deficiency. In 2024, we celebrate 100 years of salt iodization — a tremendous public health achievement.